Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/03/2003WO2003027260A2 Methods and compositions for generating homozygous mutations
04/03/2003WO2003027258A2 RECOMBINANT DNA PROCESSES USING A dNTP MIXTURE CONTAINING MODIFIED NUCLEOTIDES
04/03/2003WO2003027257A2 Methods of controlling gene expression and gene silencing
04/03/2003WO2003027254A2 15625 receptor, a novel g-protein coupled receptor
04/03/2003WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
04/03/2003WO2003027249A2 High-protein-phenotype-associated plant genes
04/03/2003WO2003027248A2 Antibody inhibitors of gdf-8 and uses thereof
04/03/2003WO2003027246A2 Antagonists
04/03/2003WO2003027244A2 Antisense oligonucleotides and methods to induce tumor cell death
04/03/2003WO2003027243A2 Phytate polynucleotides and methods of use
04/03/2003WO2003027241A2 Animal integration vector and methods for its use
04/03/2003WO2003027240A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor
04/03/2003WO2003027239A2 Melanin-concentrating hormone receptor antagonist binding protein
04/03/2003WO2003027237A2 Method of modulating or examining ku70 levels in cells
04/03/2003WO2003027236A2 Systems, methods and kits for remote genetic analysis and consultation
04/03/2003WO2003027233A2 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon
04/03/2003WO2003027231A2 Polynucleotide encoding adapter protein, pmn29
04/03/2003WO2003027229A2 Antisense modulation of rip2 expression
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027227A2 Usp-3like deubiquitinating enzyme gene disruptions, compositions and methods related thereto
04/03/2003WO2003027224A1 Optoinjection methods
04/03/2003WO2003027151A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003WO2003027147A2 Human coagulation factor vii polypeptides
04/03/2003WO2003027146A1 Use of cardiotrophin in hepatic diseases
04/03/2003WO2003027145A1 Cell death inducer, cells and animals expressing the same and method of screening anti-cell death remedy
04/03/2003WO2003027143A2 Gene and protein relating to hepatocellular carcinoma
04/03/2003WO2003027142A1 Novel g protein-coupled receptor
04/03/2003WO2003027141A1 Plant polypeptides and polynucleotides encoding same
04/03/2003WO2003027122A2 Lanthanide binding tags
04/03/2003WO2003026767A2 Lysin-deficient bacteriophages having reduced immunogenicity
04/03/2003WO2003026696A1 Method of controlling proliferation of cancer cells and cell death
04/03/2003WO2003026691A2 Use of hmgb1 for the activation of dendritic cells
04/03/2003WO2003026690A1 Incapacitated whole-cell immunogenic bacterial compositions
04/03/2003WO2003026689A1 Autologous growth factor cocktail composition, method of production and use
04/03/2003WO2003026688A1 Biphasic liposomes containing immunogen and cpg, for stimulating an immune response
04/03/2003WO2003026590A2 Biological control of nanoparticles
04/03/2003WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
04/03/2003WO2003026566A2 Atlastin
04/03/2003WO2003026418A2 Methods and compositions for regulation of cell death in plants
04/03/2003WO2003026417A2 Method of increasing expression of heterologous proteins in plants
04/03/2003WO2003026409A2 Kv1.7 potassium channel disruptions, compositions and methods relating thereto
04/03/2003WO2003026408A1 Model animal with overexpression of regucalcin
04/03/2003WO2003026407A1 Glycerol kinase gene disruptions, compositions and methods related thereto
04/03/2003WO2003026404A2 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026403A2 Ctsz disruptions, compositions and methods relating thereto
04/03/2003WO2003026402A2 Carboxypeptidase n (cpn) disruptions compositions and methods relating thereto
04/03/2003WO2003026401A2 Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO
04/03/2003WO2003026399A2 Gng4 gene disruptions, compositions and methods related thereto
04/03/2003WO2003026398A2 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026396A2 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
04/03/2003WO2003026395A2 Mo54 gene disruptions, compositions and methods related thereto
04/03/2003WO2003026394A2 Cathepsin g (ctsg) disruptions, compositions and methods relating thereto
04/03/2003WO2003026390A2 Plant reproduction polynucleotides and methods of use
04/03/2003WO2003026389A2 Manipulation of plant polysaccharide synthases
04/03/2003WO2003011889A3 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression
04/03/2003WO2003006487A8 Modulation of phosphoinositide 3-kinase activity
04/03/2003WO2003006104A3 Lymphatic endothelial cells materials and methods
04/03/2003WO2003002722A3 T cell regulatory genes and methods of use thereof
04/03/2003WO2002103009A3 Optimisation of synthetic catalysts by means of directed evolution
04/03/2003WO2002100317A3 Targeted particles and methods of using the same
04/03/2003WO2002099111A3 Anther-specific taa1 genes encoding fatty acyl co-a reductases, and uses thereof
04/03/2003WO2002099052A3 Opns as modifiers of the p53 pathway and methods of use
04/03/2003WO2002099051A3 Nits as modifiers of the p53 pathway and methods of use
04/03/2003WO2002098208A3 Tobacco biomass utilization
04/03/2003WO2002090585A3 Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
04/03/2003WO2002088338A3 Method for replicating the hepatitis c virus
04/03/2003WO2002088336A3 Genetically modified yt cell line and use thereof
04/03/2003WO2002081743A3 Polynucleotide analysis using combinatorial pcr
04/03/2003WO2002081742A3 Method for the detection of cytochrome b mutations in fungi
04/03/2003WO2002081523A3 Method for preparing and selecting antibodies
04/03/2003WO2002079400A3 Methods for isolating genes from microorganisms
04/03/2003WO2002078612A3 Thrombopoietin (tpo) synthebody for stimulation of platelet production
04/03/2003WO2002077178A3 Method of screening for agents that regulate the shedding of membrane bound proteins and methods of use
04/03/2003WO2002077161A3 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses
04/03/2003WO2002074230A3 A dna molecule encoding a variant paraoxonase and uses thereof
04/03/2003WO2002072836A3 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
04/03/2003WO2002070694A3 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002068665A3 Constitutive promoter from arabidopsis
04/03/2003WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES
04/03/2003WO2002066513A3 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof
04/03/2003WO2002061139A3 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
04/03/2003WO2002059306A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/03/2003WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/03/2003WO2002057294A3 Zinc finger proteins for dna binding and gene regulation in plants
04/03/2003WO2002055739A3 Nucleic acid extraction solution and use thereof
04/03/2003WO2002055699A3 Socs (suppressor of cytokine signaling)
04/03/2003WO2002050245A3 Novel cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
04/03/2003WO2002044419A3 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/03/2003WO2002044211A3 Endozepine like protein, polynucleotide encoding them and methods of using the same
04/03/2003WO2002042444A8 Fungal gene cluster associated with pathogenesis
04/03/2003WO2002040670A3 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain
04/03/2003WO2002038760A3 Regulation of human extracellular calcium-sensing g protein-coupled receptor
04/03/2003WO2002025270A9 Screening systems and methods for identifying modulators of xenobiotic metabolism
04/03/2003WO2002024921A3 3700, a novel human protein kinase and uses therefor
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003WO2002024742A3 Atp-binding cassette protein
04/03/2003WO2002024723A9 Modified factor viii
04/03/2003WO2002022874A9 Oligonucleotides for labeling oligonucleotide probes and proteins
04/03/2003WO2002022835A9 Targeted genetic manipulation using mu bacteriophage cleaved donor complex
1 ... 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 ... 4023